Product Data Sheet

Fmoc-MeVal-OSu

Catalog No. A43303

main product photo
Fmoc-MeVal-OSu is a specialized linker utilized in the synthesis of antibody-drug conjugates (ADCs). This compound facilitates the conjugation of therapeutic agents to antibodies, enhancing targeted delivery and efficacy in cancer therapies. Fmoc-MeVal-OSu is instrumental in research applications focused on developing novel ADCs for improved treatment outcomes in oncology.
Chemical Information
Catalog NumA43303
M. Wt450.48
FormulaC25H26N2O6
Purity>98%
Storageat -20 °C 3 years (powder form); at -20 °C 6 months (Solution base)
CAS No.863971-49-7
Synonyms
SMILESO=C(CCC1=O)N1OC([C@H](C(C)C)N(C)C(OCC2C3=CC=CC=C3C4=CC=CC=C42)=O)=O
Biological Activity
DescriptionFmoc-MeVal-OSu is a specialized linker utilized in the synthesis of antibody-drug conjugates (ADCs). This compound facilitates the conjugation of therapeutic agents to antibodies, enhancing targeted delivery and efficacy in cancer therapies. Fmoc-MeVal-OSu is instrumental in research applications focused on developing novel ADCs for improved treatment outcomes in oncology.
RETURN POLICY
Adooq’s Unconditional Return Policy ensures a smooth online shopping experience for our customers. If you are in any way unsatisfied with your purchase, you may return any item(s) within 7 days of receiving it. In the event of product quality issues, either protocol related or product related problems, you may return any item(s) within 365 days from the original purchase date. Please follow the instructions below when returning products.
SHIPPING AND STORAGE
Adooq products are transported at room temperature. If you receive the product at room temperature, please rest assured, the Adooq Quality Inspection Department has conducted experiments to verify that the normal temperature placement of one month will not affect the biological activity of powder products. After collecting, please store the product according to the requirements described in the datasheet. Most Adooq products are stable under the recommended conditions.